ANRS1212: Conclusions Despite some impact on HSV-2, episodic treatment with ACV has no measurable impact on HIV-1 replication.
{"Image DocumentName": "ANRS1212: ConclusionsDespite some impact on HSV-2, episodic treatment with ACV has no measurable impact on HIV-1 replication.", "Image ImageDescription": "Too little/too short (5 days)? Too late? (median 7 days after ulcer first noticed by woman) Advanced HIV disease in many women. Delayed impact? Inadequate outcome (D7?), sample size, etc? Await results of other trials in Malawi and South Africa. Prevention of HSV-2 reactivations perhaps more effective in controlling HSV and HIV transmissibility. 24/05/06 - AC12 Paris.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}